NO953930D0 - Cykloalkano-indol- og -azaindol-derivater - Google Patents

Cykloalkano-indol- og -azaindol-derivater

Info

Publication number: NO953930D0
Authority: NO; Norway
Prior art keywords: opt; substd; alkyl; phenyl; alkoxy
Prior art date: 1994-10-04

Application number

NO953930A

Other languages

English (en)

Other versions

NO953930L (no

NO305365B1 (no

Inventor

Ulrich Muller

Richard Connell

Siegfried Goldmann

Rudi Grutzmann

Martin Beuck

Hilmar Bischoff

Dirk Denzer

Anke Domdey-Bette

Stefan Wohlfeil

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-04

Filing date

1995-10-03

Publication date

1995-10-03

1995-10-03 Application filed by Bayer Ag filed Critical Bayer Ag

1995-10-03 Publication of NO953930D0 publication Critical patent/NO953930D0/no

1996-04-09 Publication of NO953930L publication Critical patent/NO953930L/no

1999-05-18 Publication of NO305365B1 publication Critical patent/NO305365B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/02—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

NO953930A 1994-10-04 1995-10-03 Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter NO305365B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4435477A DE4435477A1 (de)	1994-10-04	1994-10-04	Cycloalkano-indol- und -azaindol-derivate

Publications (3)

Publication Number	Publication Date
NO953930D0 true NO953930D0 (no)	1995-10-03
NO953930L NO953930L (no)	1996-04-09
NO305365B1 NO305365B1 (no)	1999-05-18

Family

ID=6529939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953930A NO305365B1 (no)	1994-10-04	1995-10-03	Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter

Country Status (35)

Country	Link
US (6)	US5684014A (no)
EP (1)	EP0705831B1 (no)
JP (1)	JP3901234B2 (no)
KR (1)	KR100355986B1 (no)
CN (2)	CN1050605C (no)
AT (1)	ATE255580T1 (no)
AU (1)	AU700609B2 (no)
CA (1)	CA2159546C (no)
CZ (1)	CZ291348B6 (no)
DE (2)	DE4435477A1 (no)
DK (1)	DK0705831T3 (no)
DZ (1)	DZ1934A1 (no)
EE (1)	EE03527B1 (no)
ES (1)	ES2211890T3 (no)
FI (2)	FI113048B (no)
HN (1)	HN1995009160A (no)
HR (1)	HRP950505B1 (no)
HU (1)	HU225052B1 (no)
IL (3)	IL115493A (no)
MA (1)	MA23683A1 (no)
MY (1)	MY117282A (no)
NO (1)	NO305365B1 (no)
NZ (1)	NZ280130A (no)
PH (1)	PH31400A (no)
PL (1)	PL183154B1 (no)
PT (1)	PT705831E (no)
RU (1)	RU2157803C2 (no)
SG (1)	SG63528A1 (no)
SI (1)	SI0705831T1 (no)
SK (1)	SK284260B6 (no)
SV (1)	SV1995000062A (no)
TN (1)	TNSN95098A1 (no)
TW (1)	TW448175B (no)
UA (1)	UA44700C2 (no)
ZA (1)	ZA958297B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19525028A1 (de) *	1995-07-10	1997-01-16	Bayer Ag	Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
US6774236B1 (en)	1996-04-04	2004-08-10	Bayer Aktiengesellschaft	Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido [1,2A]indolcarbocyclic acids and their activated derivatives
DE19613549A1 (de) *	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide
DE19619950A1 (de)	1996-04-17	1997-10-23	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide
EP0802192A1 (de) *	1996-04-17	1997-10-22	Bayer Ag	Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19615265A1 (de) *	1996-04-18	1997-12-04	Bayer Ag	Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
CA2331036A1 (en) *	1998-05-01	1999-11-11	Daniel Jon Sall	Spla2 inhibitor ester
DE69914563T2 (de) *	1998-10-30	2004-12-16	Eli Lilly And Co., Indianapolis	Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
WO2000071502A1 (en) *	1999-05-25	2000-11-30	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE19929065A1 (de) *	1999-06-25	2000-12-28	Bayer Ag	Kombination von MTP-Inhibitoren und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
DE19934610A1 (de) *	1999-07-23	2001-01-25	Bayer Ag	Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
HK1054039B (zh) *	2000-03-15	2010-04-16	萨诺费－阿文蒂斯德国有限公司	取代的β-咔啉
EP1134221A1 (en) *	2000-03-15	2001-09-19	Aventis Pharma Deutschland GmbH	Substituted beta-carbolines as lkB kinase inhibitors
WO2001074817A1 (en) *	2000-03-30	2001-10-11	Yamanouchi Pharmaceutical Co., Ltd.	Hydrazide derivatives
DE10030375A1 (de) *	2000-06-21	2002-01-03	Bayer Ag	Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
HUP0401858A3 (en) *	2001-01-31	2009-06-29	Lundbeck & Co As H	Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
NZ531890A (en) *	2002-02-28	2006-02-24	Japan Tobacco Inc	Ester compound and medicinal use thereof
US20050239780A1 (en) *	2002-05-31	2005-10-27	Akira Suga	Tetrahydropyran derivative
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
WO2004063156A1 (en) *	2003-01-08	2004-07-29	Biovitrum Ab	Novel indole derivates as fabp-4 inhibitors
WO2005051382A1 (ja) *	2003-11-28	2005-06-09	Astellas Pharma Inc.	脂質低下作用増強剤
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
CA2910191C (en)	2004-03-05	2022-03-08	The Trustees Of The Univeristy Of Pennsylvania	The use of mtp inhibitors for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005230397B2 (en) *	2004-04-09	2010-04-08	Elanco Animal Health Ireland Limited	Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
US20060030623A1 (en) *	2004-07-16	2006-02-09	Noboru Furukawa	Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
FR2873694B1 (fr) *	2004-07-27	2006-12-08	Merck Sante Soc Par Actions Si	Nouveaux aza-indoles inhibiteurs de la mtp et apob
US8101774B2 (en) *	2004-10-18	2012-01-24	Japan Tobacco Inc.	Ester derivatives and medicinal use thereof
AU2005297923B2 (en) *	2004-10-25	2010-12-23	Japan Tobacco Inc.	Solid medicinal preparation improved in solubility and stability and process for producing the same
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
JP2008542255A (ja) *	2005-05-27	2008-11-27	ファイザー・プロダクツ・インク	肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
CA2617654A1 (en) *	2005-08-04	2007-02-08	Pfizer Limited	Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
CA2626461A1 (en) *	2005-10-18	2007-04-26	Aegerion Pharmaceuticals	Compositions for lowering serum cholesterol and/or triglycerides
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
WO2007096763A2 (en) *	2006-02-23	2007-08-30	Pfizer Limited	Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US20080051427A1 (en) *	2006-05-18	2008-02-28	Fritz Schuckler	Pharmaceutical Compositions and Methods of Using Same
CN101583593A (zh)	2006-11-13	2009-11-18	辉瑞产品公司	二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
ATE547394T1 (de)	2006-12-01	2012-03-15	Bristol Myers Squibb Co	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
WO2008079398A1 (en) *	2006-12-21	2008-07-03	Aegerion Pharmaceuticals, Inc.	Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor
RU2338745C1 (ru) *	2007-03-21	2008-11-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124384A2 (en) *	2007-04-03	2008-10-16	Aegerion Pharmaceuticals, Inc.	Combinations of mtp inhibitors with cholesterol absorption inhibitors or interferon for treating hepatitis c
JP5530438B2 (ja) *	2008-08-06	2014-06-25	ファイザー・リミテッド	Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
PT2968284T (pt)	2013-03-14	2021-06-28	Osteoqc Inc	Derivados alquilamina de harmina para promoção de crescimento ósseo
CA2960101C (en)	2014-09-05	2024-05-21	Allosteros Therapeutics, Inc.	Substituted carboline derivative and compositions thereof useful as camkii inhibitors
CN108218862B (zh) *	2018-02-07	2020-06-23	贵州医科大学	α-卡波林类衍生物在制备抗心肌缺氧复氧损伤药物中的应用
CN110467560B (zh) *	2018-05-09	2025-11-25	深圳微芯生物科技股份有限公司	一种苯基氨基丙酸钠衍生物、其制备方法和应用
EP3837241A4 (en)	2018-08-14	2022-05-18	Osteoqc Inc.	FLUOROUS SS CARBOLINE COMPOUNDS
BR112021002614A2 (pt)	2018-08-14	2021-05-04	Osteoqc Inc.	compostos pirrol-dipiridina
AU2021316011A1 (en)	2020-07-29	2023-02-09	Amryt Pharmaceuticals Inc.	Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patients

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH501623A (de) *	1967-12-18	1971-01-15	Ruetgerswerke Ag	Verfahren zur Herstellung von 2-Chlorpyridin und seinen Derivaten
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
EP0234708B1 (en) *	1986-01-23	1991-02-27	Merck Frosst Canada Inc.	Tetrahydrocarbazole 1-alkanoic acids
US4940719A (en) *	1986-03-27	1990-07-10	Merck Frosst Canada, Inc.	Tetrahydrocarbazole esters, pharmaceutical compositions and use
US4775680A (en) *	1987-07-21	1988-10-04	Merck & Co., Inc.	Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
CA1326030C (en) *	1987-07-21	1994-01-11	John W. Gillard	Cyclohept[b]indolealkanoic acids
GB9101375D0 (en) *	1991-01-22	1991-03-06	Erba Carlo Spa	N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4112533A1 (de) *	1991-04-17	1992-10-22	Bayer Ag	Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de)	1991-04-26	1992-10-29	Bayer Ag	Heterocyclisch substituierte phenylessigsaeurederivate
DE4308788A1 (de) *	1993-03-18	1994-09-22	Bayer Ag	Hetero-tricyclisch-substituierte Phenyl-cyclohexan-carbonsäurederivate
DE4435477A1 (de) *	1994-10-04	1996-04-11	Bayer Ag	Cycloalkano-indol- und -azaindol-derivate
DE19613549A1 (de)	1996-04-04	1997-10-09	Bayer Ag	Verfahren zur Herstellung von enantiomerenreinen Cycloalkano-indol- und azaindol-carbonsäuren und deren aktivierte Derivate
DE19615119A1 (de) *	1996-04-17	1997-10-23	Bayer Ag	Neue Arylessigsäureamide

1994
- 1994-10-04 DE DE4435477A patent/DE4435477A1/de not_active Withdrawn
1995
- 1995-02-07 HN HN1995009160A patent/HN1995009160A/es unknown
- 1995-09-21 SI SI9530693T patent/SI0705831T1/xx unknown
- 1995-09-21 AT AT95114877T patent/ATE255580T1/de not_active IP Right Cessation
- 1995-09-21 EP EP95114877A patent/EP0705831B1/de not_active Expired - Lifetime
- 1995-09-21 DE DE59510839T patent/DE59510839D1/de not_active Expired - Lifetime
- 1995-09-21 ES ES95114877T patent/ES2211890T3/es not_active Expired - Lifetime
- 1995-09-21 PT PT95114877T patent/PT705831E/pt unknown
- 1995-09-21 DK DK95114877T patent/DK0705831T3/da active
- 1995-09-27 HR HR950505A patent/HRP950505B1/xx not_active IP Right Cessation
- 1995-09-27 AU AU32920/95A patent/AU700609B2/en not_active Ceased
- 1995-09-28 US US08/535,698 patent/US5684014A/en not_active Expired - Lifetime
- 1995-09-29 CA CA2159546A patent/CA2159546C/en not_active Expired - Fee Related
- 1995-09-29 NZ NZ280130A patent/NZ280130A/en not_active IP Right Cessation
- 1995-10-02 DZ DZ950116A patent/DZ1934A1/fr active
- 1995-10-02 KR KR1019950033651A patent/KR100355986B1/ko not_active Expired - Fee Related
- 1995-10-02 IL IL11549395A patent/IL115493A/xx not_active IP Right Cessation
- 1995-10-02 FI FI954681A patent/FI113048B/fi active
- 1995-10-02 MA MA24027A patent/MA23683A1/fr unknown
- 1995-10-02 IL IL12964199A patent/IL129641A0/xx unknown
- 1995-10-02 TN TNTNSN95098A patent/TNSN95098A1/fr unknown
- 1995-10-02 TW TW084110247A patent/TW448175B/zh active
- 1995-10-02 IL IL12964195A patent/IL129641A/xx not_active IP Right Cessation
- 1995-10-03 RU RU95117070/04A patent/RU2157803C2/ru not_active IP Right Cessation
- 1995-10-03 NO NO953930A patent/NO305365B1/no not_active IP Right Cessation
- 1995-10-03 SG SG1995001478A patent/SG63528A1/en unknown
- 1995-10-03 EE EE9500071A patent/EE03527B1/xx not_active IP Right Cessation
- 1995-10-03 UA UA95104372A patent/UA44700C2/uk unknown
- 1995-10-03 HU HU9502891A patent/HU225052B1/hu not_active IP Right Cessation
- 1995-10-03 PH PH51415A patent/PH31400A/en unknown
- 1995-10-03 JP JP27966495A patent/JP3901234B2/ja not_active Expired - Fee Related
- 1995-10-03 ZA ZA958297A patent/ZA958297B/xx unknown
- 1995-10-03 SK SK1239-95A patent/SK284260B6/sk not_active IP Right Cessation
- 1995-10-03 CZ CZ19952567A patent/CZ291348B6/cs not_active IP Right Cessation
- 1995-10-03 PL PL95310756A patent/PL183154B1/pl not_active IP Right Cessation
- 1995-10-04 SV SV1995000062A patent/SV1995000062A/es active IP Right Grant
- 1995-10-04 MY MYPI95002964A patent/MY117282A/en unknown
- 1995-10-04 CN CN95117117A patent/CN1050605C/zh not_active Expired - Fee Related
- 1995-10-04 CN CNB981260853A patent/CN1183111C/zh not_active Expired - Fee Related
1997
- 1997-07-03 US US08/887,781 patent/US6245775B1/en not_active Expired - Lifetime
1999
- 1999-05-17 US US09/313,035 patent/US6265431B1/en not_active Expired - Lifetime
2000
- 2000-12-08 FI FI20002693A patent/FI108791B/fi active
- 2000-12-11 US US09/734,955 patent/US20020147209A1/en not_active Abandoned
2001
- 2001-03-21 US US09/814,263 patent/US6479503B2/en not_active Expired - Lifetime
2002
- 2002-07-18 US US10/198,315 patent/US6858622B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6858622B2 (en)	2005-02-22
US6265431B1 (en)	2001-07-24
DE4435477A1 (de)	1996-04-11
CN1183111C (zh)	2005-01-05
NZ280130A (en)	1996-05-28
KR100355986B1 (ko)	2003-01-06
US20020147209A1 (en)	2002-10-10
NO953930L (no)	1996-04-09
US6479503B2 (en)	2002-11-12
SV1995000062A (es)	1996-07-10
JP3901234B2 (ja)	2007-04-04
MY117282A (en)	2004-06-30
US20020055635A1 (en)	2002-05-09
EP0705831A3 (de)	1997-01-22
HRP950505B1 (en)	2002-04-30
HU225052B1 (en)	2006-05-29
CZ256795A3 (en)	1996-04-17
EP0705831A2 (de)	1996-04-10
UA44700C2 (uk)	2002-03-15
IL129641A (en)	2000-08-31
CA2159546A1 (en)	1996-04-05
RU2157803C2 (ru)	2000-10-20
PH31400A (en)	1998-10-29
EE9500071A (et)	1996-04-15
FI954681A7 (fi)	1996-04-05
DZ1934A1 (fr)	2002-02-17
DK0705831T3 (da)	2004-04-05
FI108791B (fi)	2002-03-28
US6245775B1 (en)	2001-06-12
ZA958297B (en)	1996-05-06
AU3292095A (en)	1996-04-18
HU9502891D0 (en)	1995-11-28
CA2159546C (en)	2010-12-14
PT705831E (pt)	2004-04-30
CZ291348B6 (cs)	2003-02-12
HK1005139A1 (en)	1998-12-24
US20030149073A1 (en)	2003-08-07
FI113048B (fi)	2004-02-27
FI954681A0 (fi)	1995-10-02
SG63528A1 (en)	1999-03-30
ES2211890T3 (es)	2004-07-16
IL115493A0 (en)	1996-01-19
FI20002693L (fi)	2000-12-08
PL183154B1 (pl)	2002-05-31
JPH08225526A (ja)	1996-09-03
AU700609B2 (en)	1999-01-07
IL129641A0 (en)	2000-02-29
MA23683A1 (fr)	1996-07-01
IL115493A (en)	1999-10-28
DE59510839D1 (de)	2004-01-15
CN1050605C (zh)	2000-03-22
HRP950505A2 (en)	1997-08-31
PL310756A1 (en)	1996-04-15
TW448175B (en)	2001-08-01
SI0705831T1 (en)	2004-02-29
CN1130631A (zh)	1996-09-11
US5684014A (en)	1997-11-04
EE03527B1 (et)	2001-10-15
EP0705831B1 (de)	2003-12-03
SK284260B6 (sk)	2004-12-01
NO305365B1 (no)	1999-05-18
SK123995A3 (en)	1996-06-05
HN1995009160A (es)	2000-04-24
CN1224715A (zh)	1999-08-04
TNSN95098A1 (fr)	1996-02-06
KR960014126A (ko)	1996-05-22
ATE255580T1 (de)	2003-12-15
HUT73240A (en)	1996-07-29

Publication	Publication Date	Title
DE59510839D1 (de)	2004-01-15	Cycloalkano-indol- und -azaindol-derivate
PL310460A1 (en)	1996-03-18	Novel derivatives of imidazopyridine, method of obtaining them and drugs containing such derivatives
ATE204269T1 (de)	2001-09-15	Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AU2819992A (en)	1993-05-13	Hiv protease inhibitors useful for the treatment of aids
FR2619111B1 (fr)	1991-01-11	Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
HU9600914D0 (en)	1996-05-28	4-indolylpiperazinyl derivatives
ATE197794T1 (de)	2000-12-15	Benzyloxy-substituierte phenylglycinolamide als arzneimittel
AU6193196A (en)	1997-02-20	Substituted 4H-pyrans
GR3032394T3 (en)	2000-05-31	Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators

Legal Events

Date	Code	Title	Description
2011-05-30	MM1K	Lapsed by not paying the annual fees